CORRECTION
Friday, 10 September, 2004
An article published on September 8, headlined 'Nucleonics challenges Benitec-CSIRO RNAI patent' contained errors relating to the timing of the filing of key patents.
It should have stated that a patent application by The Carnegie Institution of Washington and The University of Massachusetts (the Fire-Mello invention) was first filed in the US in December 1997. The Fire-Mello invention has an earlier priority date than the Benitec and CSIRO applications, which were first filed in Australia.
A patent application by Syngenta, directed to a vector for enhancing the inhibition of a selected target gene, was also filed before the Benitec and CSIRO applications.
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
Archer completes potassium sensing alpha prototype
Quantum technology company Archer Materials Limited has developed an early Biochip prototype...
